e-learning
resources
London 2016
Monday, 05.09.2016
Viral infections in different respiratory conditions: from the bedside to the lab
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of respiratory viruses on airflow decline after allogenic hematopoietic stem cell transplantation
Camille de Seynes (Bordeaux, France), Camille de Seynes, Hervé Fleury, Noël Milpied, Reza Tabrizi, Stéphane Vigouroux, Claire Dromer, Chantal Raherison, Elodie Blanchard
Source:
International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Session:
Viral infections in different respiratory conditions: from the bedside to the lab
Session type:
Thematic Poster
Number:
2599
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Camille de Seynes (Bordeaux, France), Camille de Seynes, Hervé Fleury, Noël Milpied, Reza Tabrizi, Stéphane Vigouroux, Claire Dromer, Chantal Raherison, Elodie Blanchard. Influence of respiratory viruses on airflow decline after allogenic hematopoietic stem cell transplantation. Eur Respir J 2016; 48: Suppl. 60, 2599
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effect of extracorporeal photopheresis on respiratory function in hematopoietic stem cell transplant recipients
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014
Respiratory infections in autologus stem cell transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 560s
Year: 2006
Pulmonary function testing pre and after allogeneic hematopoietic cell transplantation for hematological malignancies
Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues
Year: 2014
Multiple breath washout can facilitate the diagnosis of lung graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease
Year: 2016
Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation
Source: Eur Respir J, 51 (5) 1702617; 10.1183/13993003.02617-2017
Year: 2018
Bronchiolitis obliterans following haematopoietic stem cell transplantation
Source: Eur Respir J 2007; 29: 1007-1019
Year: 2007
Utility of biomarkers in the management of respiratory diseases in hematopoietic stem cell transplant
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
Noninfectious pulmonary complications of haematopoietic stem cell transplantation
Source: Eur Respir Rev, 29 (156) 190119; 10.1183/16000617.0119-2019
Year: 2020
Restrictive chronic lung function decline after haematopoietic stem cell transplantation
Source: Eur Respir J 2016; 47: 336-339
Year: 2016
Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated?
Source: Eur Respir J 2005; 25: 402-405
Year: 2005
Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipients
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008
Home spirometry in bronchiolitis obliterans after allogeneic haematopoietic cell transplant
Source: Eur Respir J, 52 (1) 1702328; 10.1183/13993003.02328-2017
Year: 2018
Pulmonary function changes following allogeneic haematopoietic cell transplantation
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016
Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation
Source: Eur Respir J 2011; 38: 470-472
Year: 2011
Pulmonary infiltrates in allogenic hematopoietic stem cell transplantation recipients
Source: Eur Respir J 2002; 20: Suppl. 38, 476s
Year: 2002
Clinical course of patients with bronchiolitis obliterans after hematopoietic stem cell transplantation
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Asthma and atopy after allogeneic hematopoietic stem cell transplantation in children
Source: Annual Congress 2009 - Paediatric respiratory epidemiology: respiratory infections and rare diseases
Year: 2009
Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept